Skip to main content
Fig. 1 | Inflammation and Regeneration

Fig. 1

From: Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy

Fig. 1

In vivo anti-tumor effect of iNKT cell-targeted immunotherapy. a Metastasis of B16 melanoma after administrating αGalCer or vehicle in wild-type, iNKT-deficient (Jα18-/-), and iNKT (Rag2-/-, Vα14/Vβ8.2 TCR transgenic) mice. b Melanoma antigens in metastasized livers measured by radioimmunoassay. Figures are adapted with permission from Kawano et al., PNAS, 1998 [13], Copyright (1998) National Academy of Sciences, U.S.A. (PNAS is not responsible for the accuracy of this translation.)

Back to article page